Stay updated with breaking news from Nasdaq Blcm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Trading Down 6.6 % Shares of BLCM stock opened at $0.07 on Friday. Bellicum Pharmaceuticals has a 12 month low of $0.06 and a […]
StockNews.com initiated coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report published on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Performance Shares of BLCM opened at $0.09 on Friday. Bellicum Pharmaceuticals has a 12 month low of $0.06 and a 12 month high […]
StockNews.com started coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report issued on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Performance Shares of BLCM opened at $0.14 on Wednesday. The company’s fifty day moving average is $0.17 and its 200-day moving average is […]
StockNews.com initiated coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research report released on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Price Performance Shares of NASDAQ:BLCM opened at $0.19 on Monday. Bellicum Pharmaceuticals has a fifty-two week low of $0.06 and a fifty-two […]
StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report released on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Trading Down 20.0 % Shares of BLCM opened at $0.20 on Friday. The stock has a fifty day moving average price of $0.21 […]